Loading
Renaissance,Incorporated Stock: price and insider trades · Japan
株式会社ルネサンス
Renaissance,Incorporated: what insiders have been doing
Insider filings for Renaissance,Incorporated are scarce in the EDINET (Japan FSA) feed, the latest one published on 7 February 2023. This page will fill in as new trades are disclosed. These figures are compiled from regulatory filings published by EDINET (Japan FSA). They describe what insiders did and are not a recommendation.
Insider Decl.
1
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 22,586 of 24,148 companies
18.0
score / 100
Value25
Quality11
FCF yld0.8%
Earn yld-11%
EV/EBITDA23.9x
ROE-19%
Gross mgn8.4%
Net mgn-3.2%
Debt/EBITDA14.9x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
JP¥980
Analyst consensus
0.00/5
Income statement
RevenueJP¥64.9B
Gross profitJP¥5.4B8% margin
EBITDAJP¥2.1B3% margin
Net income-JP¥2.1B-3.2% margin
Valuation
P/Book1.9x
Beta0.15
Balance sheet & cash
Market capJP¥18.5B
Total debtJP¥30.8B
Free Cash FlowJP¥139.7M
Debt / Equity309%
Profitability & ownership
ROE-19.3%
ROA2.4%
% insiders29.2%
% institutions10.8%
Last declaration on 7 February 2023
Declarations1 total
100.0% of flowShareXTKSEDINET:S100Q2WU
1 of 1 declaration
About Renaissance,Incorporated
株式会社ルネサンス is a Japanese company operating in the health and pharmaceutical sector. It is listed on the XTKS market.